Piramal Pharma Share Price
213.66+5.50 (+2.64%)
+2.58% past 1 Year
Corporate filings & documents
Announcements
Please refer attached file
2 days agoPlease refer attached file
2 days agoPlease refer attached file
6 days agoPlease refer attached file
6 days agoPlease refer attached file
1 week agoPlease refer attached file
1 week agoPlease refer attached file
2 weeks agoPlease refer attached file
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
3 weeks agoPlease refer attached file
3 weeks agoPlease refer attached file
3 weeks agoPlease find enclosed intimation of acquisition of additional stake in Yapan Bio Private Limited
1 month agoPlease find enclosed intimation of acquisition of additional stake in Yapan Bio Private Limited
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deutsche Bank AG
1 month agoPlease find enclosed intimation of exercise of call option for acquisition of additional equity stake in Yapan Bio Private Limited
1 month agoPlease find enclosed intimation of exercise of call option for acquisition of additional equity stake in Yapan Bio Private Limited
1 month agoIntimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoIntimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoPlease refer attachment
1 month agoPlease refer attachment
1 month agoPlease find enclosed details of Earning call Transcript held on 30th July 2026.
1 month agoPlease find enclosed details of Earning call Transcript held on 30th July 2026.
1 month agoReport of the Scrutinizer along with the voting results of the businesses transacted at the AGM
1 month agoReport of the Scrutinizer along with the voting results of the businesses transacted at the AGM
1 month agoProceedings and Voting Results of the 6th Annual General Meeting of the Company
1 month agoProceedings and Voting Results of the 6th Annual General Meeting of the Company
1 month agoPlease find enclosed intimation of audio recordings of the conference call held today 30th July 2026.
1 month agoPlease find enclosed intimation of audio recordings of the conference call held today 30th July 2026.
1 month agoPlease see enclosed Investor Presentation for Q1 FY 27
1 month agoPlease see enclosed Investor Presentation for Q1 FY 27
1 month agoPlease see enlcosed Press Release for Q1 FY 27
1 month agoPlease see enlcosed Press Release for Q1 FY 27
1 month agoPlease find enlcosed UFR Q1 FY 27.
1 month agoPlease find enlcosed UFR Q1 FY 27.
1 month agoPlease find enclosed outcome of Board Meeting of Piramal Pharma Limited held on 29th July 2026
1 month agoPlease find enclosed outcome of Board Meeting of Piramal Pharma Limited held on 29th July 2026
1 month agoGrant of Stock Options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022
1 month agoGrant of Stock Options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022
1 month agoPlease refer attachment.
1 month agoPlease refer attachment.
1 month agoPlease find enclosed intimation of Analyst Meet scheduled to be held on 30th July 2026.
2 months agoPlease find enclosed intimation of Analyst Meet scheduled to be held on 30th July 2026.
2 months agoPiramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended 30th June 2026.
2 months agoPiramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended 30th June 2026.
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund
2 months agoSuccessful closure of US FDA Inspection at Piramal Pharmas manufacturing facility located at Sellersville (USA) facility
2 months agoSuccessful closure of US FDA Inspection at Piramal Pharmas manufacturing facility located at Sellersville (USA) facility
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
Jul 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Apr 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
Jul 2024
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Oct 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation